Effect of carvedilol on survival in severe chronic heart failure.

By M. Packer, AndrewJ. S. Coats, M. Fowler, H. Katus, H. Krum, P. Mohacsi, J. Rouleau, M. Tendera, A. Castaigne, E. Roecker and 2 more. New England Journal of Medicine, 2001

3,144 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/2afb8ca1618a2eb5f446ea79289218dc4e3b489c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. G. Fonarow
2. M. Flemmer
3. P. Marik
4. T. Horwich
5. Bernard R. Chaitman
6. Rick A. Nishimura
7. J. Halperin
8. Jose Luis Zamorano

Citations in the corpus

• Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets (2015, background): “Evidence from clinical trials shows that β-blocker therapy can improve cardiac function, decrease hospitalization, reduce symptoms and reduce the risk of death in patients with HF (CIBIS-II Investigators 1999; MERIT-HR Study Group 1999; Packer et al. 2001).”